1. Home
  2. TXG vs AVDL Comparison

TXG vs AVDL Comparison

Compare TXG & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • AVDL
  • Stock Information
  • Founded
  • TXG 2012
  • AVDL 2015
  • Country
  • TXG United States
  • AVDL Ireland
  • Employees
  • TXG N/A
  • AVDL N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • AVDL Biotechnology: Pharmaceutical Preparations
  • Sector
  • TXG Industrials
  • AVDL Health Care
  • Exchange
  • TXG Nasdaq
  • AVDL Nasdaq
  • Market Cap
  • TXG 1.6B
  • AVDL 1.8B
  • IPO Year
  • TXG 2019
  • AVDL 1996
  • Fundamental
  • Price
  • TXG $15.76
  • AVDL $23.04
  • Analyst Decision
  • TXG Buy
  • AVDL Buy
  • Analyst Count
  • TXG 13
  • AVDL 9
  • Target Price
  • TXG $14.50
  • AVDL $18.06
  • AVG Volume (30 Days)
  • TXG 3.1M
  • AVDL 5.6M
  • Earning Date
  • TXG 11-06-2025
  • AVDL 11-04-2025
  • Dividend Yield
  • TXG N/A
  • AVDL N/A
  • EPS Growth
  • TXG N/A
  • AVDL N/A
  • EPS
  • TXG N/A
  • AVDL N/A
  • Revenue
  • TXG $641,814,000.00
  • AVDL $248,517,000.00
  • Revenue This Year
  • TXG $2.07
  • AVDL $64.21
  • Revenue Next Year
  • TXG N/A
  • AVDL $30.80
  • P/E Ratio
  • TXG N/A
  • AVDL N/A
  • Revenue Growth
  • TXG 1.92
  • AVDL 79.88
  • 52 Week Low
  • TXG $6.78
  • AVDL $6.38
  • 52 Week High
  • TXG $17.70
  • AVDL $23.57
  • Technical
  • Relative Strength Index (RSI)
  • TXG 61.04
  • AVDL 85.45
  • Support Level
  • TXG $15.12
  • AVDL $18.74
  • Resistance Level
  • TXG $17.70
  • AVDL $23.56
  • Average True Range (ATR)
  • TXG 1.01
  • AVDL 0.28
  • MACD
  • TXG 0.22
  • AVDL 0.32
  • Stochastic Oscillator
  • TXG 64.37
  • AVDL 89.55

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

Share on Social Networks: